Canada - Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases
Since 2014, Canada Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases jumped by 1.2% year on year. With 5.4 Days in 2019, the country was ranked number 22 comparing other countries in Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases. Canada is overtaken by France, which was number 21 with 5.8 Days and is followed by Sweden at 5.3 Days. Germany ranked the highest with 11 Days in 2019, that is a decrease of 1.8% compared to 2018. Portugal, Czech Republic and Iceland respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +4% per year, while Switzerland recorded the worst performance at -6.8% per year.
Loading...
Date | Days |
---|---|
2019 | 5.40 |
2018 | 5.50 |
2017 | 5.30 |
2016 | 5.70 |
2015 | 5.90 |
How does Canada rank in Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases?
# | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Germany
|
11.00 | 2019 | -1.8 % | -1.9 % | View data | |
2 |
#2
Portugal
|
9.00 | 2018 | NA | -1.3 % | View data | |
21 |
#21
France
|
5.80 | 2019 | -1.7 % | -1.3 % | View data | |
22 |
#22
Canada
|
5.40 | 2019 | -1.8 % | +1.1 % | View data | |
23 |
#23
Denmark
|
5.30 | 2019 | -3.6 % | -4.6 % | View data |